Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 554 (ZNF554) is a member of the large transcription factor family known as zinc finger proteins, specifically of the Krüppel-associated box (KRAB) domain-containing C2H2 zinc finger subfamily[2][1]. ZNF554 is encoded within the KRAB-ZNF cluster on chromosome 19p13. Its expression in humans is mainly limited to the brain and placenta[2]. Functionally, ZNF554 acts as a transcriptional regulator, involved in cell differentiation, embryo development, and epigenetic gene silencing. Recent studies show ZNF554 has tumor suppressor properties in brain cancers: its decreased expression in gliomas correlates with higher tumor grade and shorter patient survival, likely due to loss of suppression of oncogenic and immune-related pathways and dysregulation of cell proliferation and cell cycle control[2]. Decreased expression also contributes to the pathogenesis of preeclampsia by impairing trophoblast invasion[2]. There are currently no known drugs targeting ZNF554, nor reported safety concerns specific to its modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 554 (ZNF554).